EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and
Patents infringement in Pharmaceuticals
MIAMI, December 28, 2012 /PRNewswire/ --
EmergingGrowth.com, a leading digital financial media company,
Reports on RVPlus, Inc., Oil and Gas and Patents infringement in
Pharmaceuticals.
Feature your company on EmergingGrowth.com. Visit
EmergingGrowth.com to find out how.
RV Plus (OTCBB: RVPL) just announced that it has generated a
total amount of $14,610,576 in
accounts receivable as of today for 2012 year from long-term
contracts with foreign governments to supply goods and services
that support carbon-emissions reduction, energy efficiency, in
addition to supporting climate change, environment, forestry,
social affairs, and agriculture.
In the past six months, the company has made entry into three
definitive material agreements with foreign government parties for
goods and services, holding a total value of $1,900,500,000 (USD), which are associated to
Civil Society Programs, collectively organized by United Nations
affiliates and Parties in Latin
America, West Indies, and Africa.
Cary Lee Peterson has told press
that he will be publishing a year-end letter to shareholders on
January 1, 2013 to recap on 2012 year
for the Company and provide details of plans for ECCO2 Tech and
partners in 2013. If RVPL can materialize these contracts in
the near term, we could see a dramatic move in the company's
valuation and share price. Please visit the Company's website
for a deeper understanding on the process.
http://www.ecco2tech.com/investors.html
Tamm Oil and Gas Corporation (OTCBB: TAMO) recently entered into
an agreement with private company CEC North Star Energy Ltd to do
work pertaining to their recently purchased additional third party
trade seismic which after reprocessing and analysis continues to
support the existence of the Bluesky channel of the Norh Star
Lands. Based on this seismic, 4 well locations were surveyed
recently and the licensing process will be initiated in the next
few weeks with an expected completion prior to break up.
Globalstar, Inc. (OTCBB: GSAT) recently announced that it
received a delisting notice from NASDAQ do to the fact that it's
share price has fallen below $1.00
per share in excess of the time period permitted by NASDAQ rules.
The company after a recent appeal to NASDAQ requested a
further extension and was denied.
The six time patent infringement in pharmaceuticals case
plaintiff Depomed (NASDAQ: DEPO) is making progress in battles.
Watson Pharmaceuticals (NYSE: WPI) withdrew its application
for the competing drug generic Gralise, and the suit against Impax
Laboratories (NASDAQ: IPXL) was dismissed after the withdrawal of
their application. The road is getting clearer as the
competition is fading. Look for Depomed to react.
About EmergingGrowth.com
By offering 100% original and unmatched content by the best
financial reporters, writers and bloggers in the business,
EmergingGrowth.com is emerging as a leading digital financial media
portal. Its services provide users, subscribers and advertisers
with a variety of content and tools through a range of online,
social media, mobile and other mobile outlets.
Since its inception, EmergingGrowth.com has distinguished itself
from other financial media companies with its sly approach to
reading between the lines in order to locate that needle in the
haystack. Sign up today to see what EmergingGrowth.com has to
offer.
NEW: Feature your company on EmergingGrowth.com.
Find out how by filling out our form at
http://emerginggrowth.com/recommend-a-company-to-feature-on-emerging-growth
Join our Linked in Group
Like us on Facebook
Disclosure
All information contained herein as well as on the
EmergingGrowth.com website is obtained from sources believed to be
reliable but not guaranteed to be accurate or all-inclusive. All
material is for informational purposes only, is only the opinion of
EmergingGrowth.com and should not be construed as an offer or
solicitation to buy or sell securities. From time to time,
EmergingGrowth.com receives compensation by the companies profiled
in its emails, press releases or on its website. If any
compensation is received it appears fully detailed in a "special
disclosure" on our website as well as on any pages or emails where
that company is located. Please check the "Special
Disclosure" link (http://www.emerginggrowth.com/special-disclosure)
and consult an investment professional before investing in anything
viewed within. In addition, Please make sure you read and
understand the Terms of Use, Privacy Policy and the Disclosure
posted on the EmergingGrowth.com website. Always remember that
investing in securities such as the ones listed within are for
high-risk tolerant individuals only and not the general public.
Whether you are an experienced investor or not, you should always
consult with a stockbroker, financial advisor, or similar before
purchasing or selling any securities viewed on any emails sent from
EmergingGrowth.com or its website.
SOURCE EmergingGrowth.com